Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT...
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion device—which involves the perivenous injection of the anti-inflammatory drug dexamethasone to improve patency...
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
Vein360 receives US FDA clearance to reprocess the Philips Visions PV 0.035, 0.018, and...
Vein360 has announced it received US Food and Drug Administration (FDA) 510(k) clearance for reprocessing the Philips Visions PV 0.035 digital intravascular ultrasound (IVUS)...
